OR WAIT 15 SECS
GE Healthcare recently announced its completion of the acquisition of Whatman, which is a global supplier of filtration technologies and products.
GE Healthcare recently announced its completion of the acquisition of Whatman, which is a global supplier of filtration technologies and products.Expanding GE Healthcare's life science research and biopharmaceutical manufacturing contribution, the acquisition enhances a key area of growth for the company. A provider of cellular and protein science research technologies, as well as tools used in biopharmaceuticals' manufacture - products such as vaccines, cell therapies and antibodies - GE Healthcare will secure substantial customer benefits through the addition of Whatman's innovative filters and membranes for laboratory research, life sciences and medical technology applications.GE Healthcare's president and CEO of life sciences business commented: "Whatman's expertise and reputation on filtration technologies and sample preparation is a great fit for our life sciences business. We believe that combining the skills of the two companies will enable GE Healthcare to create strong added value for customers in biomedical and drug discovery research."